BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33441470)

  • 21. Concordance of measures of left-ventricular hypertrophy in pediatric hypertension.
    Mirchandani D; Bhatia J; Leisman D; Kwon EN; Cooper R; Chorny N; Frank R; Infante L; Sethna C
    Pediatr Cardiol; 2014 Apr; 35(4):622-6. PubMed ID: 24253610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool.
    Goland S; Czer LS; Kass RM; Siegel RJ; Mirocha J; De Robertis MA; Lee J; Raissi S; Cheng W; Fontana G; Trento A
    J Am Coll Cardiol; 2008 Mar; 51(12):1214-20. PubMed ID: 18355661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
    Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
    Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
    Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
    Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
    Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
    Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
    Urbano-Moral JA; Gonzalez-Gonzalez AM; Maldonado G; Gutierrez-Garcia-Moreno L; Vivancos-Delgado R; De Mora-Martin M; Rodriguez-Palomares JF; Evangelista-Masip A
    J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilayer Myocardial Mechanics in Genotype-Positive Left Ventricular Hypertrophy-Negative Patients With Hypertrophic Cardiomyopathy.
    Williams LK; Misurka J; Ho CY; Chan WX; Agmon Y; Seidman C; Rakowski H; Carasso S
    Am J Cardiol; 2018 Nov; 122(10):1754-1760. PubMed ID: 30249441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial Vascular Dysfunction Is Associated With Raised Blood Pressure and Adverse Left Ventricular Remodeling in Adolescent Adiposity.
    Hauser JA; Muthurangu V; Sattar N; Taylor AM; Jones A
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009172. PubMed ID: 31707792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
    Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy.
    Monzo L; Martino A; Lanzillo C; Bencivenga S; Acitelli A; Fedele E; Salustri E; Bona RD; Maresca L; Silvetti E; Canestrelli S; Minati M; Penco M; Calò L
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):696-703. PubMed ID: 32639329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.
    Pieroni M; Chimenti C; De Cobelli F; Morgante E; Del Maschio A; Gaudio C; Russo MA; Frustaci A
    J Am Coll Cardiol; 2006 Apr; 47(8):1663-71. PubMed ID: 16631007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain analysis during exercise in patients with left ventricular hypertrophy: impact of etiology.
    Schnell F; Donal E; Bernard-Brunet A; Reynaud A; Wilson MG; Thebault C; Ridard C; Mabo P; Carré F
    J Am Soc Echocardiogr; 2013 Oct; 26(10):1163-1169. PubMed ID: 23860095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy.
    Sheikh N; Papadakis M; Schnell F; Panoulas V; Malhotra A; Wilson M; Carré F; Sharma S
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003454. PubMed ID: 26198026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population.
    Cuspidi C; Facchetti R; Bombelli M; Tadic M; Sala C; Grassi G; Mancia G
    Hypertension; 2019 Mar; 73(3):612-619. PubMed ID: 30612493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance.
    Dweck MR; Joshi S; Murigu T; Gulati A; Alpendurada F; Jabbour A; Maceira A; Roussin I; Northridge DB; Kilner PJ; Cook SA; Boon NA; Pepper J; Mohiaddin RH; Newby DE; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):50. PubMed ID: 22839417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR).
    Kis M; Dogan Y; Yildirim A; Güzel T; Bekar L; Akhan O; Dogdus M; Harbalıoğlu H; Karabulut D; Soydan E; Zoghi M; Ergene O;
    Acta Cardiol; 2022 Nov; 77(9):836-845. PubMed ID: 36222672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.
    Petersen SE; Selvanayagam JB; Francis JM; Myerson SG; Wiesmann F; Robson MD; Ostman-Smith I; Casadei B; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2005; 7(3):551-8. PubMed ID: 15959967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
    Hazari H; Belenkie I; Kryski A; White JA; Oudit GY; Thompson R; Fung T; Dehar N; Khan A
    Can J Cardiol; 2018 Aug; 34(8):1041-1047. PubMed ID: 29935990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.